JE
ABBV icon

JMAC Enterprises’s AbbVie ABBV Stock Holding History

JMAC Enterprises’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Hold
6,567
– – 0.28% 45
2026
Q1 		$1.43M Buy
6,567
+600
+10% +$133K 0.27% 47
2025
Q4 		$1.36M Buy
5,967
+500
+9% +$114K 0.26% 49
2025
Q3 		$1.27M Buy
5,467
+87
+2% +$17.7K 0.25% 53
2025
Q2 		$999K Hold
5,380
– – 0.21% 58
2025
Q1 		$1.13M Sell
5,380
-3,597
-40% -$699K 0.27% 49
2024
Q4 		$1.6M Buy
8,977
+503
+6% +$92.5K 0.25% 82
2024
Q3 		$1.67M Sell
8,474
-903
-10% -$169K 0.27% 83
2024
Q2 		$1.61M Buy
9,377
+798
+9% +$132K 0.28% 82
2024
Q1 		$1.56M Buy
8,579
+2,498
+41% +$431K 0.29% 79
2023
Q4 		$942K Buy
6,081
+297
+5% +$43.3K 0.2% 93
2023
Q3 		$862K Sell
5,784
-1
-0% -$147 0.21% 88
2023
Q2 		$779K Buy
5,785
+62
+1% +$9.09K 0.19% 94
2023
Q1 		$912K Hold
5,723
– – 0.23% 91
2022
Q4 		$925K Buy
5,723
+195
+4% +$29.9K 0.25% 91
2022
Q3 		$742K Hold
5,528
– – 0.21% 104
2022
Q2 		$847K Sell
5,528
-400
-7% -$61.1K 0.22% 104
2022
Q1 		$961K Sell
5,928
-501
-8% -$72.8K 0.23% 94
2021
Q4 		$914K Buy
+6,429
New +$759K 0.22% 95

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JMAC Enterprises's ABBV Position: Q2 2026 in Review

JMAC Enterprises held its AbbVie (ABBV) position steady in Q2 2026 at 6,567 shares worth $1.65M. The position accounts for 0.28% of the portfolio, ranked #45.

JMAC Enterprises first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.67M in Q3 2024. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • JMAC Enterprises held 6,567 shares of AbbVie worth $1.65M as of Q2 2026.
  • JMAC Enterprises left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.28% of JMAC Enterprises's portfolio in Q2 2026, its #45 holding.
  • JMAC Enterprises first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • JMAC Enterprises's AbbVie position peaked at $1.67M in Q3 2024.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.